Seroprevalence of hepatitis E virus among pregnant women and control subjects in China
Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV‐endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 an...
Saved in:
Published in | Journal of medical virology Vol. 87; no. 3; pp. 446 - 450 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.03.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV‐endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case‐control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine‐hundred and ninety pregnant women who visited hospitals for antenatal follow‐up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti‐HEV IgG and IgM antibodies by enzyme immunoassays. Socio‐demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti‐HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti‐HEV IgG positive whereas, in control subjects 25.3% of samples were anti‐HEV IgG positive, (P < 0.01). For anti‐HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China. J. Med. Virol. 87:446–450, 2015. © 2014 Wiley Periodicals, Inc. |
---|---|
AbstractList | Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P<0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China. J. Med. Virol. 87:446-450, 2015. copyright 2014 Wiley Periodicals, Inc. Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P < 0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China. Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P < 0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China.Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P < 0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China. Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P<0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China. J. Med. Virol. 87:446-450, 2015. © 2014 Wiley Periodicals, Inc. |
Author | Chen, Jia Cong, Wei Sui, Jian-Chao Zhu, Xing-Quan Qian, Ai-Dong Zhang, Xiang-Yan |
Author_xml | – sequence: 1 givenname: Wei surname: Cong fullname: Cong, Wei organization: State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, China – sequence: 2 givenname: Jian-Chao surname: Sui fullname: Sui, Jian-Chao organization: Weihai Wendeng Central Hospital, Weihai, Shandong Province, China – sequence: 3 givenname: Xiang-Yan surname: Zhang fullname: Zhang, Xiang-Yan organization: Affilliated Hospital of Medical College, Qingdao University, Shandong Province, Qingdao, China – sequence: 4 givenname: Ai-Dong surname: Qian fullname: Qian, Ai-Dong organization: College of Animal Science and Technology, Jilin Agricultural University, Jilin Province, Changchun, China – sequence: 5 givenname: Jia surname: Chen fullname: Chen, Jia organization: State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Gansu Province, Lanzhou, China – sequence: 6 givenname: Xing-Quan surname: Zhu fullname: Zhu, Xing-Quan email: Correspondence to: Xing-Quan Zhu, State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 1 Xujiaping, Yanchangbu, Lanzhou, Gansu Province 730046, China., zhuxingquan@caas.cn organization: State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25164987$$D View this record in MEDLINE/PubMed |
BookMark | eNqN0U1PFTEYBeDGYOSCLvwDpokbXQy87fRjupQbBAz4ERESN02n04FeZ9prO3OBf-_ABRYkGlfdPOdNes4W2ggxOIReE9ghAHR30a92KANePUMzAkoUCiTZQDMgTBRCEL6JtnJeAEClKH2BNikngqlKztDZd5fiMrmV6VywDscWX7qlGfzgM97HK5_GjE0fwwWe1EUwYcBXsXcBm9BgG8OQYofzWC-cHTL2Ac8vfTAv0fPWdNm9un-30Y-P-6fzw-L4y8HR_MNxYZliVWEMhaZVkpaGK2jAKlkz5tqmbpwSYBkFaErDqpZQWnMlGt6W0qrK1txVRpbb6N367jLF36PLg-59tq7rTHBxzJoIzkRVKkX_h04dAhdsom-f0EUcU5g-MikmpFTiTr25V2Pdu0Yvk-9NutEP5U7g_RrYFHNOrn0kBPTtcHoaTt8NN9ndJ9b6YZrhtmDju38lrnznbv5-Wn86OXtIFOuEz4O7fkyY9EsLWUquzz8f6D04_Hb-8_REfy3_AKZqt5o |
CitedBy_id | crossref_primary_10_5144_0256_4947_2020_136 crossref_primary_10_18632_oncotarget_23381 crossref_primary_10_1186_s12884_020_03116_2 crossref_primary_10_1371_journal_pone_0238987 crossref_primary_10_1016_S2468_1253_19_30342_5 crossref_primary_10_1080_22221751_2023_2276336 crossref_primary_10_1016_j_actatropica_2017_04_033 crossref_primary_10_1016_j_flm_2018_11_003 crossref_primary_10_1016_j_actatropica_2019_02_004 crossref_primary_10_1016_j_vaccine_2019_08_003 crossref_primary_10_1186_s12985_021_01616_x crossref_primary_10_1016_j_bjid_2015_08_009 crossref_primary_10_1007_s40572_016_0096_x crossref_primary_10_1002_jmv_24203 crossref_primary_10_1186_s12985_024_02576_8 crossref_primary_10_1016_j_rvsc_2024_105429 crossref_primary_10_3390_healthcare9020133 crossref_primary_10_3390_pathogens12091072 crossref_primary_10_1080_14767058_2019_1582630 crossref_primary_10_1080_14767058_2020_1852206 crossref_primary_10_1002_jmv_24693 crossref_primary_10_1002_jmv_24871 crossref_primary_10_1155_2017_4067108 crossref_primary_10_1186_s12879_015_1308_y crossref_primary_10_1016_j_jcv_2016_07_010 crossref_primary_10_1186_s12985_020_01343_9 crossref_primary_10_1111_tbed_14437 |
Cites_doi | 10.1186/1743-422X-5-158 10.1016/j.jhep.2007.12.008 10.1016/j.jviromet.2009.11.028 10.1186/1756-0500-3-103 10.1002/jmv.23804 10.1186/1743-422X-6-108 10.3201/eid1712.110371 10.3201/eid1112.051041 10.1016/j.jcv.2013.08.030 10.1016/j.ijid.2012.11.026 10.1002/jmv.21033 10.1002/jmv.23429 10.1007/BF02722743 10.1128/JCM.01466-09 10.3201/eid1809.120241 10.1371/journal.pone.0061351 10.1093/infdis/jit409 10.1016/j.bjid.2013.02.006 10.5812/hepatmon.6194 |
ContentType | Journal Article |
Copyright | 2014 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2014 Wiley Periodicals, Inc. |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 7T2 7U1 |
DOI | 10.1002/jmv.24058 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic Health and Safety Science Abstracts (Full archive) Risk Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic Risk Abstracts Health & Safety Science Abstracts |
DatabaseTitleList | Risk Abstracts MEDLINE MEDLINE - Academic Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1096-9071 |
EndPage | 450 |
ExternalDocumentID | 3562643941 25164987 10_1002_jmv_24058 JMV24058 ark_67375_WNG_B0HQWZTM_P |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China China, People's Rep., Shandong Prov., Qingdao China, People's Rep., Shandong Prov., Weihai |
GeographicLocations_xml | – name: China – name: China, People's Rep., Shandong Prov., Weihai – name: China, People's Rep., Shandong Prov., Qingdao |
GrantInformation_xml | – fundername: Science Fund for Creative Research Groups of Gansu Province funderid: 1210RJIA006 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3O- 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AI. AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS ECGQY EJD ELTNK EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TUS UB1 V2E VH1 W8V W99 WBKPD WHG WIB WIH WIJ WIK WJL WNSPC WOHZO WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~KM ~WT AAHQN AAIPD AAMMB AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AEFGJ AEYWJ AFWVQ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY ALVPJ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 7T2 7U1 |
ID | FETCH-LOGICAL-c4948-aa20df9723a590d0c97b44efdbde960c4200d3a48f122b596d5f37c98cb5e8a73 |
IEDL.DBID | DR2 |
ISSN | 0146-6615 1096-9071 |
IngestDate | Fri Jul 11 12:43:02 EDT 2025 Fri Jul 11 11:56:03 EDT 2025 Sat Jul 26 02:14:47 EDT 2025 Mon Jul 21 06:06:28 EDT 2025 Tue Jul 01 02:24:33 EDT 2025 Thu Apr 24 22:51:15 EDT 2025 Wed Aug 20 07:25:54 EDT 2025 Wed Oct 30 09:56:13 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | seroprevalence pregnant women control subjects Hepatitis E Virus China |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2014 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4948-aa20df9723a590d0c97b44efdbde960c4200d3a48f122b596d5f37c98cb5e8a73 |
Notes | ark:/67375/WNG-B0HQWZTM-P Science Fund for Creative Research Groups of Gansu Province - No. 1210RJIA006 ArticleID:JMV24058 istex:00BD35E9E011B36B9382F899FF07D087300FC562 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 25164987 |
PQID | 1646779664 |
PQPubID | 105515 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1654683992 proquest_miscellaneous_1652400564 proquest_journals_1646779664 pubmed_primary_25164987 crossref_primary_10_1002_jmv_24058 crossref_citationtrail_10_1002_jmv_24058 wiley_primary_10_1002_jmv_24058_JMV24058 istex_primary_ark_67375_WNG_B0HQWZTM_P |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | March 2015 |
PublicationDateYYYYMMDD | 2015-03-01 |
PublicationDate_xml | – month: 03 year: 2015 text: March 2015 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: London |
PublicationTitle | Journal of medical virology |
PublicationTitleAlternate | J. Med. Virol |
PublicationYear | 2015 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, Ayeh-Kumi PF, Adiku TK. 2009. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J 6:108. Dong C, Dai X, Liang J, Dong M, Meng J. 2012. Seroprevalence of hepatitis e virus varies considerably among chinese provinces. Hepat Mon 12:386-390. Caron M, Kazanji M. 2008. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J 5:158. Guo QS, Yan Q, Xiong JH, Ge SX, Shih JW, Ng MH, Zhang J, Xia NS. 2010. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 48:317-318. Goumba CM, Yandoko-Nakouné ER, Komas NP. 2010. A fatal case of acute hepatitis E among pregnant women, Central African Republic. BMC Res Notes 3:103. Pelosi E, Clarke I. 2008. Hepatitis E: A complex and global disease. Emerg Health Threats J 1:e8. Huang F, Ma T, Li L, Zeng W, Jing S. 2013. Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China. Braz J Infect Dis 17:16-17. Chaussade H, Rigaud E, Allix A, Carpentier A, Touzé A, Delzescaux D, Choutet P, Garcia-Bonnet N, Coursaget P. 2013. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol 58:504-508. Labrique AB, Sikder SS, Krain LJ, West KP Jr, Christian P, Rashid M, Nelson KE. 2012. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 18:1401-1404. Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. 2003. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 70:3739. Mateos-Lindemann ML, Diez-Aguilar M, Galdamez AL, Galán JC, Moreno A, Pérez-Gracia MT. 2014. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 86:71-74. Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, Kurata Y, Ishida M, Sakamoto S, Takeda N, Miyamura T. 2005. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 11:1958-11960. Kumar S, Subhadra S, Singh B, Panda BK. 2013. Hepatitis E virus: The current scenario. Int J Infect Dis 17: e 228-233. Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst J, Kmush B, Nelson KE. 2013. An exploratory case control study of risk factors for hepatitis E in rural Bangladesh. PLoS One 8:61351. Bigaillon C, Tessé S, Lagathu G, Nicand E. 2010. Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J Virol Methods 164:127-130. Purcell RH, Emerson SU. 2008. Hepatitis E: an emerging awareness of an old disease. J Hepatol 48:494-503. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. 2008. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 80:95-101. Chiu DM, Chan MC, Yeung AC, Ngai KL, Chan PK. 2013. Seroprevalence of hepatitis E virus in Hong Kong, 2008-2009. J Med Virol 85:459-461. Jacobs C, Chiluba C, Phiri C, Lisulo MM, Chomba M, Hill PC, Ijaz S, Kelly P. 2014. Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: Strong association with HIV and environmental enteropathy. J Infect Dis 209:652-657. Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J. 2011. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17:2309-23012. 2013; 58 2010; 48 2013; 17 2014; 209 2003; 70 2013; 85 2008; 48 2010; 164 2008; 5 2012; 18 2009; 6 2010; 3 2011; 17 2008; 1 2013; 8 2012; 12 2005; 11 2008; 80 2014; 86 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_21_1 e_1_2_7_20_1 Pelosi E (e_1_2_7_19_1) 2008; 1 |
References_xml | – reference: Chiu DM, Chan MC, Yeung AC, Ngai KL, Chan PK. 2013. Seroprevalence of hepatitis E virus in Hong Kong, 2008-2009. J Med Virol 85:459-461. – reference: Labrique AB, Sikder SS, Krain LJ, West KP Jr, Christian P, Rashid M, Nelson KE. 2012. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 18:1401-1404. – reference: Guo QS, Yan Q, Xiong JH, Ge SX, Shih JW, Ng MH, Zhang J, Xia NS. 2010. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 48:317-318. – reference: Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst J, Kmush B, Nelson KE. 2013. An exploratory case control study of risk factors for hepatitis E in rural Bangladesh. PLoS One 8:61351. – reference: Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, Kurata Y, Ishida M, Sakamoto S, Takeda N, Miyamura T. 2005. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 11:1958-11960. – reference: Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. 2003. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 70:3739. – reference: Dong C, Dai X, Liang J, Dong M, Meng J. 2012. Seroprevalence of hepatitis e virus varies considerably among chinese provinces. Hepat Mon 12:386-390. – reference: Pelosi E, Clarke I. 2008. Hepatitis E: A complex and global disease. Emerg Health Threats J 1:e8. – reference: Bigaillon C, Tessé S, Lagathu G, Nicand E. 2010. Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J Virol Methods 164:127-130. – reference: Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J. 2011. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17:2309-23012. – reference: Mateos-Lindemann ML, Diez-Aguilar M, Galdamez AL, Galán JC, Moreno A, Pérez-Gracia MT. 2014. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 86:71-74. – reference: Chaussade H, Rigaud E, Allix A, Carpentier A, Touzé A, Delzescaux D, Choutet P, Garcia-Bonnet N, Coursaget P. 2013. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol 58:504-508. – reference: Huang F, Ma T, Li L, Zeng W, Jing S. 2013. Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China. Braz J Infect Dis 17:16-17. – reference: Jacobs C, Chiluba C, Phiri C, Lisulo MM, Chomba M, Hill PC, Ijaz S, Kelly P. 2014. Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: Strong association with HIV and environmental enteropathy. J Infect Dis 209:652-657. – reference: Purcell RH, Emerson SU. 2008. Hepatitis E: an emerging awareness of an old disease. J Hepatol 48:494-503. – reference: Goumba CM, Yandoko-Nakouné ER, Komas NP. 2010. A fatal case of acute hepatitis E among pregnant women, Central African Republic. BMC Res Notes 3:103. – reference: Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. 2008. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 80:95-101. – reference: Kumar S, Subhadra S, Singh B, Panda BK. 2013. Hepatitis E virus: The current scenario. Int J Infect Dis 17: e 228-233. – reference: Caron M, Kazanji M. 2008. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J 5:158. – reference: Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, Ayeh-Kumi PF, Adiku TK. 2009. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J 6:108. – volume: 17 start-page: 2309 year: 2011 end-page: 23012 article-title: Hepatitis E virus antibodies in blood donors, France publication-title: Emerg Infect Dis – volume: 17 start-page: 228 year: 2013 end-page: 233 article-title: Hepatitis E virus: The current scenario publication-title: Int J Infect Dis – volume: 8 start-page: 61351 year: 2013 article-title: An exploratory case control study of risk factors for hepatitis E in rural Bangladesh publication-title: PLoS One – volume: 86 start-page: 71 year: 2014 end-page: 74 article-title: Patients infected with HIV are at high‐risk for hepatitis E virus infection in Spain publication-title: J Med Virol – volume: 17 start-page: 16 year: 2013 end-page: 17 article-title: Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China publication-title: Braz J Infect Dis – volume: 48 start-page: 494 year: 2008 end-page: 503 article-title: Hepatitis E: an emerging awareness of an old disease publication-title: J Hepatol – volume: 3 start-page: 103 year: 2010 article-title: A fatal case of acute hepatitis E among pregnant women, Central African Republic publication-title: BMC Res Notes – volume: 58 start-page: 504 year: 2013 end-page: 508 article-title: Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals publication-title: J Clin Virol – volume: 85 start-page: 459 year: 2013 end-page: 461 article-title: Seroprevalence of hepatitis E virus in Hong Kong, 2008‐2009 publication-title: J Med Virol – volume: 209 start-page: 652 year: 2014 end-page: 657 article-title: Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: Strong association with HIV and environmental enteropathy publication-title: J Infect Dis – volume: 6 start-page: 108 year: 2009 article-title: Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana publication-title: Virol J – volume: 70 start-page: 3739 year: 2003 article-title: Mother‐to‐child transmission of hepatitis E virus infection publication-title: Indian J Pediatr – volume: 48 start-page: 317 year: 2010 end-page: 318 article-title: Prevalence of hepatitis E virus in Chinese blood donors publication-title: J Clin Microbiol – volume: 164 start-page: 127 year: 2010 end-page: 130 article-title: Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection publication-title: J Virol Methods – volume: 5 start-page: 158 year: 2008 article-title: Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas publication-title: Virol J – volume: 11 start-page: 1958 year: 2005 end-page: 11960 article-title: Hepatitis E virus transmission from wild boar meat publication-title: Emerg Infect Dis – volume: 18 start-page: 1401 year: 2012 end-page: 1404 article-title: Hepatitis E, a vaccine‐preventable cause of maternal deaths publication-title: Emerg Infect Dis – volume: 1 start-page: e8 year: 2008 article-title: Hepatitis E: A complex and global disease publication-title: Emerg Health Threats J – volume: 12 start-page: 386 year: 2012 end-page: 390 article-title: Seroprevalence of hepatitis e virus varies considerably among chinese provinces publication-title: Hepat Mon – volume: 80 start-page: 95 year: 2008 end-page: 101 article-title: Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response publication-title: J Med Virol – ident: e_1_2_7_5_1 doi: 10.1186/1743-422X-5-158 – ident: e_1_2_7_20_1 doi: 10.1016/j.jhep.2007.12.008 – ident: e_1_2_7_4_1 doi: 10.1016/j.jviromet.2009.11.028 – ident: e_1_2_7_9_1 doi: 10.1186/1756-0500-3-103 – ident: e_1_2_7_18_1 doi: 10.1002/jmv.23804 – ident: e_1_2_7_2_1 doi: 10.1186/1743-422X-6-108 – volume: 1 start-page: e8 year: 2008 ident: e_1_2_7_19_1 article-title: Hepatitis E: A complex and global disease publication-title: Emerg Health Threats J – ident: e_1_2_7_17_1 doi: 10.3201/eid1712.110371 – ident: e_1_2_7_16_1 doi: 10.3201/eid1112.051041 – ident: e_1_2_7_6_1 doi: 10.1016/j.jcv.2013.08.030 – ident: e_1_2_7_13_1 doi: 10.1016/j.ijid.2012.11.026 – ident: e_1_2_7_3_1 doi: 10.1002/jmv.21033 – ident: e_1_2_7_7_1 doi: 10.1002/jmv.23429 – ident: e_1_2_7_21_1 doi: 10.1007/BF02722743 – ident: e_1_2_7_10_1 doi: 10.1128/JCM.01466-09 – ident: e_1_2_7_14_1 doi: 10.3201/eid1809.120241 – ident: e_1_2_7_15_1 doi: 10.1371/journal.pone.0061351 – ident: e_1_2_7_12_1 doi: 10.1093/infdis/jit409 – ident: e_1_2_7_11_1 doi: 10.1016/j.bjid.2013.02.006 – ident: e_1_2_7_8_1 doi: 10.5812/hepatmon.6194 |
SSID | ssj0008922 |
Score | 2.2535543 |
Snippet | Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women.... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 446 |
SubjectTerms | Adolescent Adult Animals Case-Control Studies China China - epidemiology control subjects Disease transmission Environmental Exposure Enzyme-Linked Immunosorbent Assay Female Hepatitis Hepatitis Antibodies - blood Hepatitis E - epidemiology Hepatitis E Virus Hepatitis E virus - immunology Humans Immunoglobulin G - blood Immunoglobulin M - blood Pets Pregnancy Pregnancy Complications, Infectious - epidemiology Pregnant Women Risk Factors Seroepidemiologic Studies seroprevalence Virology Young Adult |
Title | Seroprevalence of hepatitis E virus among pregnant women and control subjects in China |
URI | https://api.istex.fr/ark:/67375/WNG-B0HQWZTM-P/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.24058 https://www.ncbi.nlm.nih.gov/pubmed/25164987 https://www.proquest.com/docview/1646779664 https://www.proquest.com/docview/1652400564 https://www.proquest.com/docview/1654683992 |
Volume | 87 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1baxQxFA6lgvji_TK2ShQRX2Y7m0kmCX1SaV0KW1R6Q4SQ2-i2dbbs7JTirzcncymViuLbwJyBXM518uU7CL0i49xl2oXqhIhQoBBiU50LmjLpObTFEUTCfefpbjHZpztH7GgFbfZ3YVp-iOGHG1hG9Ndg4NrUG5ekocc_zkchHDG46AtYLUiIPl9SRwnZniAET5CGGMR6VqGMbAxfXolFN2BZL65LNK_mrTHwbN9BX_sht3iTk1GzNCP78zc2x_-c0110u0tI8dtWg-6hFV_dRzen3ZH7A3QQvAl0SgkaCU4Az0v83QMMezmr8RY-ny2aGseWRThIfQNcDY60DlhXDndIeFw3Bn741HhW4diy-yHa397aez9Ju2YMqQUGmVRrkrkSepRpJjOXWckNpb50xvlQBVkazM3lmopyTIhhsnCszLmVwhrmheb5I7RazSv_BOFi7LQljnojGbU8k5ZT7zNPuSmMGBcJetNvi7IdUzk0zDhVLccyUWGdVFynBL0cRM9aeo7rhF7HvR0k9OIE8GycqcPdD-pdNvl0-GVvqj4maL3ffNWZcq2AgI3zUBXSBL0YXgcjhJMVXfl5AzIMsLjsLzK0EMADnKDHrWINAwpJZkGl4GHmUT3-PBe1Mz2ID0__XXQN3QppHmuRc-todblo_LOQSi3N82gzvwB3yxhM |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ta9QwGA9zA90X33XVqVFE_NJbL02aBPyisnnO9VC5vSBISJNUz2lPrtch_vXmSXsdk4nit0KfQpM8r8mT3w-hx2SY2kRbX50Q4QsUQkysU0FjJh0HWhxBJNx3zsfZaJ_uHrGjFfRseRemxYfoN9zAMoK_BgOHDemtU9TQL99OBj4eMXEBrQGjdyio3p-CRwnZniF4XxD7KMSWuEIJ2eo_PRON1mBif5yXap7NXEPo2bmCPi5_uu04OR40i2Jgfv6G5_i_o7qKLnc5KX7eKtE1tOKq6-hi3p2630AH3qEAWYpXSvADeFbizw46sRfTGm_jk-m8qXFgLcJe6hO01uCA7IB1ZXHXDI_rpoA9nxpPKxxYu2-i_Z3tyctR3PExxAZAZGKtSWJLoCnTTCY2MZIXlLrSFtb5QshQb3E21VSUQ0IKJjPLypQbKUzBnNA8vYVWq1nlNhDOhlYbYqkrJKOGJ9Jw6lziKC-yQgyzCD1drosyHVg5cGZ8VS3MMlF-nlSYpwg96kW_twgd5wk9CYvbS-j5MbS0caYOx6_Ui2T07vDDJFdvI7S5XH3VWXOtAIONc18Y0gg97F97O4TDFV25WQMyDNpx2V9kaCYACjhCt1vN6n_I55kZlYL7kQf9-PNY1G5-EB7u_LvoA3RpNMn31N7r8Zu7aN1nfaxtpNtEq4t54-75zGpR3A8G9AvoHxxn |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD7UFoov3i_RqqOI-JJtdjKTmcEntV3X6i5VeqMIw9zSrtVs2WyK-OudSbIplYriWyAnMJdzzZz5PoDnuJ_aRFlfnWDuCxSMTaxSTmIqHAu0OByLcN95NM6Gu2TrgB4swavFXZgGH6L74RYso_bXwcBPbb5-Dhr69ftZz4cjyq_ACskSHlR64_M5dhQXzRGCdwWxD0J0ASuU4PXu0wvBaCWs64_LMs2LiWsdeQbX4ctizE3DyUmvmuue-fkbnON_TuoGXGszUvS6UaGbsOSKW7A6as_cb8OedyeBKsWrZPACaJqjYxf6sOeTEm2is8msKlHNWYS81FForEE1rgNShUVtKzwqKx3--JRoUqCas_sO7A42d94O45aNITYBQiZWCic2DyRliorEJkYwTYjLrbbOl0GGeHuzqSI872OsqcgszVNmBDeaOq5YeheWi2nh7gPK-lYZbInTghLDEmEYcS5xhOlM834WwcvFtkjTQpUHxoxvsgFZxtKvk6zXKYJnnehpg89xmdCLem87CTU7CQ1tjMr98Tv5Jhl-2j_cGcntCNYWmy9bWy5lQGBjzJeFJIKn3WtvheFoRRVuWgUZGppx6V9kSMYDEHAE9xrF6gbks8yMCM78zGv1-PNc5NZor3548O-iT2B1e2MgP74ff3gIV33KR5suujVYns8q98inVXP9uDafX5xoGx8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Seroprevalence+of+hepatitis+E+virus+among+pregnant+women+and+control+subjects+in+China&rft.jtitle=Journal+of+medical+virology&rft.au=Cong%2C+Wei&rft.au=Sui%2C+Jian-Chao&rft.au=Zhang%2C+Xiang-Yan&rft.au=Qian%2C+Ai-Dong&rft.date=2015-03-01&rft.eissn=1096-9071&rft.volume=87&rft.issue=3&rft.spage=446&rft_id=info:doi/10.1002%2Fjmv.24058&rft_id=info%3Apmid%2F25164987&rft.externalDocID=25164987 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon |